Klaus Nickisch
Corporate Officer/Principal bei University of Witten/Herdecke
Profil
Klaus Nickisch was the founder of Evestra, Inc. (founded in 2007) where he held the title of Director, Chief Scientific Officer & Executive VP from 2007 to 2020.
He is currently working as a Principal at the University of Witten since 2002 and also serves as a Member-Advisory Board at Laborchemie Apolda GmbH.
Dr. Nickisch previously worked as a Director at EpiVax, Inc. and as a Senior Vice President-Global Project Management at Berlex Pharmaceuticals, Inc. He obtained his graduate and doctorate degrees from the Technical University of Berlin.
Aktive Positionen von Klaus Nickisch
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Witten/Herdecke | Corporate Officer/Principal | 01.01.2002 |
Laborchemie Apolda GmbH
 Laborchemie Apolda GmbH Chemicals: Major DiversifiedProcess Industries Laborchemie Apolda GmbH is a private company that manufactures and wholesales chemicals and pharmaceutical ingredients. The company is based in Apolda, Germany. | Corporate Officer/Principal | 07.12.2009 |
Ehemalige bekannte Positionen von Klaus Nickisch
| Unternehmen | Position | Ende |
|---|---|---|
Evestra, Inc.
 Evestra, Inc. BiotechnologyHealth Technology Evestra, Inc. provides biopharmaceutical research and development services. It focuses in conducting research and product development in women's healthcare. The firm is involved in addressing unmet medical need in the areas of endometriosis, fibroids, hormone replacement therapy (HRT), and hormonal-dependent breast cancer. The company was founded by Ze’ev Shaked and Klaus Nickisch in October 2007 and is headquartered in Schertz, TX. | Gründer | 01.08.2020 |
| Berlex Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
EpiVax, Inc.
 EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Direktor/Vorstandsmitglied | - |
Ausbildung von Klaus Nickisch
| Technical University of Berlin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
| Berlex Pharmaceuticals, Inc. | |
Laborchemie Apolda GmbH
Laborchemie Apolda GmbH Chemicals: Major DiversifiedProcess Industries Laborchemie Apolda GmbH is a private company that manufactures and wholesales chemicals and pharmaceutical ingredients. The company is based in Apolda, Germany. | Process Industries |
Evestra, Inc.
Evestra, Inc. BiotechnologyHealth Technology Evestra, Inc. provides biopharmaceutical research and development services. It focuses in conducting research and product development in women's healthcare. The firm is involved in addressing unmet medical need in the areas of endometriosis, fibroids, hormone replacement therapy (HRT), and hormonal-dependent breast cancer. The company was founded by Ze’ev Shaked and Klaus Nickisch in October 2007 and is headquartered in Schertz, TX. | Health Technology |
